Better Reimbursement Decision-Making Based on Expected Cost-Effectiveness- Using Value of Information Decision Analysis to Improve The Design and Efficacy of A Phase Iii Program for Erlotinib
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2616
https://www.valueinhealthjournal.com/article/S1098-3015(15)04692-6/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
2027
First Page :
A700
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04692-6&doi=10.1016/j.jval.2015.09.2616